Pulmonary embolism after dexamethasone treatment for COVID-19: a case report

BACKGROUND: Although the RECOVERY trial showed that dexamethasone was efficacious for the treatment of coronavirus disease 2019 (COVID-19), its impact on the risk of pulmonary embolism (PE) and other serious procoagulant events was not assessed. CASE PRESENTATION: Here we report the case of a previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hidenori, Iwasaki, Yoshinobu, Watanabe, Takayasu, Ichinose, Naoki, Oda, Toshimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938737/
https://www.ncbi.nlm.nih.gov/pubmed/35317729
http://dx.doi.org/10.1186/s12879-022-07228-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938737/
https://www.ncbi.nlm.nih.gov/pubmed/35317729
http://dx.doi.org/10.1186/s12879-022-07228-2

Ejemplares similares